-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at CPHI Milan 2024
Category:
发布时间：2024-10-12
【概要描述】
On October 8, the 2024 CPHI Milan European Pharmaceutical Ingredients Exhibition was held at the Milan International Fairgrounds in Italy. Shijiazhuang Sihua Pharmaceutical Group showcased its key products—including active pharmaceutical ingredients and finished dosage forms—as well as new offerings at the event.
On October 8, the 2024 CPHI Milan European Exhibition for Pharmaceutical Raw Materials was held at the Milan International Fairgrounds in Italy. Shijiazhuang Sihua Pharmaceutical Group showcased its key products—including active pharmaceutical ingredients and finished dosage forms—as well as new offerings at the event.
According to available information, CPHI is a specialized trade fair in the international pharmaceutical raw materials and intermediates sector and a renowned brand exhibition in this field. Held annually on a rotating basis in Germany, France, and Spain, it forms part of a globally distributed platform for professional exhibitions and showcases in the pharmaceutical industry. As one of the world’s most concentrated and highly attended specialized exhibitions for pharmaceutical raw materials, intermediates, finished dosage forms, and innovative drugs, European CPHI covers the entire pharmaceutical value chain, providing global biopharmaceutical companies with a professional, international, and high-end forum for exchange and collaboration, while fostering the sustained development of the global pharmaceutical industry and the advancement of international business partnerships.
At the exhibition, the Group’s booth features a sleek, open design in blue-and-white tones with three sides fully open, conveying an image of openness, inclusiveness, and win-win cooperation. The display panels highlight the Group’s integrated “API + formulation” development achievements, showcasing both time-tested flagship APIs—such as caffeine, azithromycin, and metronidazole—known for their high quality and strong market reputation, as well as more than 60 new specialty API varieties and a wide array of export-oriented formulations. This diverse product portfolio has drawn keen attention from international business visitors.
In the negotiation area, the Group’s API and formulation business teams engaged in active discussions with both new and existing international customers on cooperation and development. “By leveraging the trade fair, we have further strengthened our business relationships with existing international partners and proactively explored new business opportunities. During the event, we held business talks with more than 30 international clients and secured multiple export orders for APIs such as caffeine and azithromycin,” said the head of the Group’s API Foreign Trade Center. The center added that it will continue to intensify its efforts to expand into international markets, providing high-quality product supply and services to an increasing number of global pharmaceutical companies.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091